STUDY OBJECTIVE: To examine the relationship between packed RBC (pRBC) transfusion and the development of ICU-acquired bloodstream infections (BSIs) DESIGN: Secondary analysis of a large, prospective, observational study of transfusion practice in critically ill patients. SETTING: A total of 284 adult ICUs in the United States. PATIENTS: Critically ill adults who lacked BSIs both at ICU admission and 48 h after ICU admission. INTERVENTIONS: None. MEASUREMENTS AND RESULTS: BSIs were prospectively tracked in this study, and diagnosis of a new BSI represented the primary end point. Transfusions administered in the ICU prior to development of a BSI were also prospectively recorded. Of 4,892 patients enrolled in this investigation, 3,502 patients lacked BSIs both at ICU admission and 48 h later. Among these individuals, 117 patients (3.3%) had an ICU-acquired BSI. In multivariate analysis adjusting for severity of illness, primary diagnosis, use of mechanical ventilation, placement of central venous catheters, and ICU length of stay, three variables were independently associated with diagnosis of a new BSI: baseline treatment with cephalosporins (odds ratio [OR], 1.84; 95% confidence interval [CI], 1.26 to 2.68), higher sequential organ failure assessment score measured on ICU days 3 to 4 (OR, 1.11; 95% CI, 1.06 to 1.16), and pRBC transfusion (OR, 2.23; 95% CI, 1.43 to 3.52). The relationship between pRBC transfusion and BSI was evident with both small transfusion volumes (OR with 1- to 2-U pRBC transfusion, 1.89; 95% CI, 1.10 to 3.23) and larger transfusion volumes (OR with > 4-U pRBC transfusion, 2.63; 95% CI, 1.52 to 4.53). CONCLUSIONS: pRBC transfusion is associated with subsequent ICU-acquired BSI. Avoiding unnecessary transfusions may decrease the incidence of BSIs.
STUDY OBJECTIVE: To examine the relationship between packed RBC (pRBC) transfusion and the development of ICU-acquired bloodstream infections (BSIs) DESIGN: Secondary analysis of a large, prospective, observational study of transfusion practice in critically illpatients. SETTING: A total of 284 adult ICUs in the United States. PATIENTS: Critically ill adults who lacked BSIs both at ICU admission and 48 h after ICU admission. INTERVENTIONS: None. MEASUREMENTS AND RESULTS: BSIs were prospectively tracked in this study, and diagnosis of a new BSI represented the primary end point. Transfusions administered in the ICU prior to development of a BSI were also prospectively recorded. Of 4,892 patients enrolled in this investigation, 3,502 patients lacked BSIs both at ICU admission and 48 h later. Among these individuals, 117 patients (3.3%) had an ICU-acquired BSI. In multivariate analysis adjusting for severity of illness, primary diagnosis, use of mechanical ventilation, placement of central venous catheters, and ICU length of stay, three variables were independently associated with diagnosis of a new BSI: baseline treatment with cephalosporins (odds ratio [OR], 1.84; 95% confidence interval [CI], 1.26 to 2.68), higher sequential organ failure assessment score measured on ICU days 3 to 4 (OR, 1.11; 95% CI, 1.06 to 1.16), and pRBC transfusion (OR, 2.23; 95% CI, 1.43 to 3.52). The relationship between pRBC transfusion and BSI was evident with both small transfusion volumes (OR with 1- to 2-U pRBC transfusion, 1.89; 95% CI, 1.10 to 3.23) and larger transfusion volumes (OR with > 4-U pRBC transfusion, 2.63; 95% CI, 1.52 to 4.53). CONCLUSIONS:pRBC transfusion is associated with subsequent ICU-acquired BSI. Avoiding unnecessary transfusions may decrease the incidence of BSIs.
Authors: Kevin Beier; Sabitha Eppanapally; Heidi S Bazick; Domingo Chang; Karthik Mahadevappa; Fiona K Gibbons; Kenneth B Christopher Journal: Crit Care Med Date: 2011-02 Impact factor: 7.598
Authors: Brian M Fuller; Mithil Gajera; Christa Schorr; David Gerber; R Phillip Dellinger; Joseph Parrillo; Sergio Zanotti Journal: J Emerg Med Date: 2012-03-24 Impact factor: 1.484
Authors: Jennifer Muszynski; Jyotsna Nateri; Kathleen Nicol; Kristin Greathouse; Lisa Hanson; Mark Hall Journal: Transfusion Date: 2011-10-07 Impact factor: 3.157
Authors: M Todd Greene; Sanjay Saint; David Ratz; Latoya Kuhn; Jennifer Davis; Payal K Patel; Mary A M Rogers Journal: Am J Infect Control Date: 2018-11-20 Impact factor: 2.918
Authors: Heidi S Bazick; Domingo Chang; Karthik Mahadevappa; Fiona K Gibbons; Kenneth B Christopher Journal: Crit Care Med Date: 2011-08 Impact factor: 7.598
Authors: David J Murphy; David Howard; Angela Muriithi; Pedro Mendez-Tellez; Jonathan Sevransky; Carl Shanholtz; Giora Netzer; Peter J Pronovost; Dale M Needham Journal: Crit Care Med Date: 2009-06 Impact factor: 7.598
Authors: Amartya Mukhopadhyay; Hwee S Yip; Dimple Prabhuswamy; Yiong H Chan; Jason Phua; Tow K Lim; Patricia Leong Journal: Crit Care Date: 2010-01-27 Impact factor: 9.097